Manorama Industries’ board has approved a ₹460 crore capital expenditure plan over the next two to three years, aimed at enhancing manufacturing capacity and investing in new projects. The company also announced the re-designation of Mr. Deep Saraf as Deputy Chief Executive Officer and Dr. Krishnadath Bhaggan as Deputy Chief Executive Officer for Business Development and Vice President – R&D.
Significant Capital Expenditure Plan
The board of Manorama Industries has approved a capital expenditure (‘Capex’) plan involving an estimated investment of approximately ₹460 crores for the next two to three years. The objective is to enhance manufacturing capacity, invest in new projects, support infrastructures, upgrade technology, and foster long-term growth. The funding may be from internal accruals, debt, or equity.
Details of the Capex Plan
The Capex plan includes several key initiatives:
Forward integration: Setting up a manufacturing facility for Cocoa Butter Alternative (CBA) with an input capacity of 75,000 metric tons per year.
Solvent Fractionation: Establishing a new Solvent Fractionation manufacturing facility for Sal, Shea, Palm, Mango, and other exotic seeds and ESOS with an input capacity of 75,000 metric tons per year.
Refinery Manufacturing: Setting up a new refinery manufacturing facility with a capacity of 90,000 metric tons per year.
Backward Integration: Establishing a processing factory in Burkina Faso with a capacity of 90,000 metric tons per year. (Subject to formation of the company in process).
The above capex plan is subject to requisite statutory/regulatory approvals and will be implemented in a phased manner.
Key Management Re-designations
The board also approved the following re-designations:
Mr. Deep Saraf: Re-designated as “Deputy Chief Executive Officer Chief Coordinator”.
Dr. Krishnadath Bhaggan: Re-designated as “Deputy Chief Executive Officer Business Development & Vice President – R&D”.
Other Key Decisions
Re-appointment: Approved the re-appointment of Mr. Nipun Sumanlal Mehta as an Independent Director for another term of 5 (five) years.
Postal Ballot: Approved a postal ballot notice for seeking consent of members of the Company.
Auditors: The Unaudited Financial Results for Q3 2026 and the nine months ending December 31, 2025, were reviewed and approved. Limited review was conducted by Singhi & Co, Chartered Accountants.
Source: BSE
